Back to Newsroom

Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals Announces Third Quarter 2016 Financial Results and Provides Corporate Update

Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow

CORAL GABLES, Fla., Nov. 09, 2016 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today reported financial results for the third quarter and nine months ended September 30, 2016 and provided a corporate update.

Click here to read the full release